ReviewCell proliferation2026
Unveiling Gut Homeostasis Disruption in Sepsis: Towards an Integrated Mechanistic and Translational Roadmap.
Review in Cell proliferation, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
Sepsis, a life-threatening clinical syndrome precipitated by a maladaptive host response to infection, is associated with substantial morbidity and high mortality rates. Gastrointestinal injury has gained recognition as a pivotal factor driving sepsis progression. Pathogen invasion incites oxidative stress and inflammatory cascades, leading to compromised intestinal barrier integrity and dysregulated local immunity. This results in increased gut permeability and bacterial translocation, fostering a state that can be described as 'enteric sepsis'. Moreover, multi-organ crosstalk via the gut-liver and gut-brain axes substantially amplifies systemic inflammation. The pathophysiology of sepsis-induced intestinal injury is not yet fully elucidated, and clinically applicable biomarkers or early diagnostic tools remain scarce. Targeted therapeutic strategies have yet to be validated in clinical practice. This article presents a comprehensive review of recent advances in the pathophysiology and underlying mechanisms of sepsis-induced intestinal injury, focusing on the signalling networks that disrupt intestinal homeostasis and immune equilibrium. Particular emphasis is placed on identifying key pathways and candidate biomarkers for early diagnosis and intervention. Additionally, the therapeutic potential of targeted intestinal-protective agents is evaluated, integrating insights from traditional Chinese medicine to propose a combined treatment strategy. Ultimately, this review aims to establish a translational framework to advance clinical management and therapeutic innovation for sepsis-associated intestinal dysfunction.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.